<kbd date-time="2ujmgI"></kbd><del id="CH9lE"></del> "V体育官网入口" Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil VSports app下载. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure V体育官网. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. .

Review
. 2016 Jul;33(7):833-47.
doi: 10.1007/s10815-016-0720-6. Epub 2016 May 12.

Immunogenetic contributions to recurrent pregnancy loss

Frances Grimstad  1 , Sacha Krieg  2
Affiliations
Review

Immunogenetic contributions to recurrent pregnancy loss

Frances Grimstad et al. J Assist Reprod Genet. 2016 Jul.

Abstract

While sporadic pregnancy loss is common, occurring in 15 % of pregnancies, recurrent pregnancy loss (RPL) impacts approximately 5 % of couples. Though multiple causes are known (including structural, hormonal, infectious, autoimmune, and thrombophilic causes), after evaluation, roughly half of all cases remain unexplained. The idiopathic RPL cases pose a challenging therapeutic dilemma in addition to incurring much physical and emotional morbidity. Immunogenetic causes have been postulated to contribute to these cases of RPL. Natural Killer cell, T cell expression pattern changes in the endometrium have both been shown in patients with RPL. Human leukocyte antigen (HLA) and cytokine allelic variations have also been studied as etiologies for RPL VSports手机版. Some of the results have been promising, however the studies are small and have not yet put forth outcomes that would change our current diagnosis and management of RPL. Larger database studies are needed with stricter control criteria before reasonable conclusions can be drawn. .

Keywords: HY-Antibodies; Human leukocyte antigens; Immunogenetics; Recurrent pregnancy loss; T regulatory cell V体育安卓版. .

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Fig. 1
Fig. 1
Natural killer cells. NK cells migrate from the bone marrow to the uterus in response to progesterone and estrogen [17]. NK cells detect altered MHC class 1 proteins and use perforin and granzymes to destroy extravillous trophoblastic cells [42]
Fig. 2
Fig. 2
T cells. T cell expression and regulation is an important process in the establishment and maintenance of early pregnancy. There are still many unknowns regarding their mechanisms of action. This diagram gives a general overview. Estrogen, βHCG, and G-CSF are all known to induce expression of Treg cells and migration to the endometrium [–71]. There they express IL-10, TGFβ, and TNFα [10]. TNF-α is produced by all CD4+ T cells [, –75]. IL-10 inhibits macrophages and Th1 cell proliferation [76, 77]. Th1 cells both produce and are promoted by IFN-γ [11, 72, 73, 78, 79]. They secrete IL-12 as well [41]. They can induce Th17 and NK cells. Th2 cells produce IL-4, -5, -13 [41]. IL-4 is known to inhibit Th1 [76]. IL-6 is known to promote Th2 cells [80]. Th17 are derived in response to TGFβ and IL-6 as well as inflammation [41]. They secrete IL-17, -21, -22 [, –86]
See this image and copyright information in PMC

References

    1. Jivraj S, et al. Obstetric and neonatal outcome in women with a history of recurrent miscarriage: a cohort study. Hum Reprod. 2001;16(1):102–6. doi: 10.1093/humrep/16.1.102. - DOI - PubMed
    1. Fritz MA, Speroff L. Clinical gynecologic endocrinology and infertility. 8. Philadelphia: Lippincott Williams and Wilkins; 2010.
    1. Stephenson M, Kutteh W. Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol. 2007;50(1):132–45. doi: 10.1097/GRF.0b013e31802f1c28. - DOI - PubMed
    1. Stirrat GM. Recurrent miscarriage. II: clinical associations, causes, and management. Lancet. 1990;336(8717):728–33. doi: 10.1016/0140-6736(90)92215-4. - DOI - PubMed
    1. Berry CW, et al. The Euro-Team Early Pregnancy (ETEP) protocol for recurrent miscarriage. Hum Reprod. 1995;10(6):1516–20. doi: 10.1093/HUMREP/10.6.1516. - DOI - PubMed

Publication types (VSports注册入口)

MeSH terms

"V体育ios版" LinkOut - more resources